Fish-eye disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:79292OMIM:136120E78.6
Who is this for?
Show terms as
35Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Clinical phenotype terms— hover any for plain English:

AtherosclerosisHP:0002621Decreased HDL cholesterol concentrationHP:0003233
Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

Pfizer — PHASE1

TrialNOT YET RECRUITING
Feb 2026A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

Addpharma Inc. — PHASE1

TrialRECRUITING
Jan 2026Fasted vs. Fed State Exercise

Arkansas Colleges of Health Education — PHASE2

TrialRECRUITING
Dec 2025A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A

Addpharma Inc. — PHASE1

TrialNOT YET RECRUITING
Oct 2025Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants

Pfizer — PHASE1

TrialRECRUITING
Jul 2025Pharmacokinetics of Zelquistinel in Fasted or Fed State

Syndeio Biosciences, Inc — PHASE1

TrialACTIVE NOT RECRUITING
Jul 2025A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)

Boryung Pharmaceutical Co., Ltd — PHASE1

TrialRECRUITING
Jun 2025Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects Under Fed Conditions

APR Applied Pharma Research s.a. — PHASE1

TrialNOT YET RECRUITING
Jun 2025A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin 0.4 mg Tablets, in Healthy Adult Male Subjects, Under Fed Conditions

Berlin-Chemie AG Menarini Group — PHASE1

TrialACTIVE NOT RECRUITING
Jun 2025The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects

Qilu Pharmaceutical Co., Ltd. — PHASE1

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Fish-eye disease.

View clinical trials →

No actively recruiting trials found for Fish-eye disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Fish-eye disease community →

Specialists

Showing 25 of 35View all specialists →
AB
Amaya Belanger-Quintana
Specialist
1 Fish-eye disease publication
YA
Yuichi Akasaki
Specialist
1 Fish-eye disease publication
MK
Masayuki Kuroda
Specialist
1 Fish-eye disease publication
MM
Masaaki Miyata
Specialist
1 Fish-eye disease publication
FB
Francisco Arrieta Blanco
CHELAN, WA
Specialist
1 Fish-eye disease publication
AO
Ana Álvarez ODogherty
Specialist
1 Fish-eye disease publication
CJ
Carmen Rodríguez Jiménez
Specialist
1 Fish-eye disease publication
SN
Sonia Rodríguez Novoa
Specialist
1 Fish-eye disease publication
KY
Koutaro Yokote
Specialist
1 Fish-eye disease publication
YM
Yoshiro Maezawa
Specialist
1 Fish-eye disease publication
KU
Kensuke Utatsu
Specialist
1 Fish-eye disease publication
SB
Serdar Beken
Specialist
PI on 1 active trial
MY
Misato Yamamoto
Specialist
1 Fish-eye disease publication
RN
Rora Nagasawa
Specialist
1 Fish-eye disease publication
JM
Junko Miyoshi
Specialist
1 Fish-eye disease publication
MK
Mika Kirinashizawa
Specialist
1 Fish-eye disease publication
IM
Ibtihal HH Faraj, M-B.CH.B
Specialist
PI on 1 active trial
AM
Aryan MF Jalal, M.B.CH.B
Specialist
PI on 1 active trial
EP
Eric Masson, Pharm.D.
ATHOL, MA
Specialist
PI on 3 active trials
MM
Min-Gul Kim, MD
Specialist
PI on 2 active trials
KP
Karen M Beathard, PhD
COLLEGE STATION, TX
Specialist
PI on 1 active trial
JP
Jacqueline Tan-Showyin, PhD
Specialist
PI on 1 active trial
AM
Arun D. Singh, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Fish-eye disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Fish-eye diseaseForum →

No community posts yet. Be the first to share your experience with Fish-eye disease.

Start the conversation →

Latest news about Fish-eye disease

Disease timeline:

New recruiting trial: Gut Kidney Axis in Enteric Hyperoxaluria

A new clinical trial is recruiting patients for Fish-eye disease

New recruiting trial: Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

A new clinical trial is recruiting patients for Fish-eye disease

New recruiting trial: Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants

A new clinical trial is recruiting patients for Fish-eye disease

New recruiting trial: A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

A new clinical trial is recruiting patients for Fish-eye disease

New recruiting trial: Phenylalanine, Methionine and Histidine Requirements in TPN Fed Neonates

A new clinical trial is recruiting patients for Fish-eye disease

New recruiting trial: A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

A new clinical trial is recruiting patients for Fish-eye disease

New recruiting trial: Evaluation of the Physiological Stability Variability and Robustness of NIS4

A new clinical trial is recruiting patients for Fish-eye disease

New recruiting trial: HMOs on Infant Gut Microbiota Modulation and Development of the Immune System in Healthy Infants

A new clinical trial is recruiting patients for Fish-eye disease

New recruiting trial: Fasted vs. Fed State Exercise

A new clinical trial is recruiting patients for Fish-eye disease

New recruiting trial: A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)

A new clinical trial is recruiting patients for Fish-eye disease

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Fish-eye disease

Which specialists treat Fish-eye disease?

25 specialists and care centers treating Fish-eye disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.